Capital Flow Monitor · Sponsors · CIK 1728411
DMC Biotechnologies, Inc.
2477 55TH STREET, SUITE 120, BOULDER, CO, 80301 · 720-239-7239
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$2.5M
Sold
$1.4M
% sold
56.6%
Investors
7
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | D ·current | 506(b) | $2.5M | $1.4M | 56.6% | 7 | EDGAR ↗ |
| 2025-12-30 | D | 506(b) | $1.7M | $905K | 54.5% | 4 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Jim Flatt — Executive Officer / Director, Boulder, CO
- Rob van der Meij — Director, Boulder, CO
- Josko Bobanovic — Director, Boulder, CO
-
Doug Cameron — Director, Boulder, CO
1 other raise
- ARZEDA Corp. $4.5M of $25.0M · 18.0%
-
Alastair Cooper — Director, Boulder, CO
1 other raise
- EarthOptics, Inc. $38.1M of $51.3M · 74.2%
- Matthew Lipscomb — Director, Boulder, CO
- K'Lynne Johnson — Director, Boulder, CO
- Josh Yelen — Executive Officer, Boulder, CO
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.